Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-056004
Filing Date
2022-05-04
Accepted
2022-05-04 21:01:54
Documents
1
Period of Report
2022-05-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2214456-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2214456-1_3seq1.xml 3 1584
  Complete submission text file 0001104659-22-056004.txt   3141
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 60 JUBILEE AVENUE, MILTON PARK ABINGDON OXFORDSHIRE X0 OX14 4RX
Business Address
Brewer Joanna Elizabeth (Reporting) CIK: 0001923834 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37368 | Film No.: 22893648